AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Buying Aliada Therapeutics would hand AbbVie a clinical-stage Alzheimer’s medicine and a drugmaking technology that may be useful for a variety of brain diseases.

Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug

Roche’s prized breast cancer pill fails closely watched study

March 9, 2026

Biosafety agency, Open varsity collaborate to ensure confidence in technology – EnviroNews

March 9, 2026

Source link

AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Roche’s prized breast cancer pill fails closely watched study

Biosafety agency, Open varsity collaborate to ensure confidence in technology – EnviroNews

‘It’s a hustle’: Fish market folk in Barbados experience more struggle since Hurricane Beryl

Responsible AI practices help companies create value

Responsible AI practices help companies create value

Leave a Reply Cancel reply

RECOMMENDED NEWS

Access to public land through corner crossing remains legal

Eritrea: World Down Syndrome Day Observed

S.Sudan Deploys First Unified Forces After Peace Deal

Northrop Reviews US Navy E-2D Hawkeye Avionics Upgrades

POPULAR NEWS

Mahama attends Liberia’s 178th independence anniversary

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Related posts

‘It’s a hustle’: Fish market folk in Barbados experience more struggle since Hurricane Beryl

Responsible AI practices help companies create value

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS